Urovant Sciences Ltd. UROV
— —
Day range unavailable
52-week range unavailable
Valuation
P/E -1.9×
FY 2017 5y median -6.1× FY 2020
P/S 0.0×
FY 2017 5y median 0.0× FY 2020
P/B -4.8×
FY 2017 5y median 26.7× FY 2020
P/FCF -2.7×
FY 2017 5y median -6.4× FY 2020
EV/EBITDA -2.1×
FY 2017 5y median -5.7× FY 2020
EV/Sales 0.0×
FY 2017 5y median 0.0× FY 2020
FCF Yield -37.2%
FY 2017 5y median -23.3% FY 2020
Profitability
Gross Margin 0.0%
FY 2017 5y median 0.0% FY 2020
Operating Margin 0.0%
FY 2017 5y median 0.0% FY 2020
Net Margin 0.0%
FY 2017 5y median 0.0% FY 2020
ROE 253.0%
FY 2017 5y median -336.5% FY 2020
ROIC -441.3%
FY 2017 5y median -482.2% FY 2020
ROA -231.8%
FY 2017 5y median -258.7% FY 2020
Growth (YoY)
Revenue 0.0%
FY 2017 FY 2020
Operating Income -28.9%
FY 2017 FY 2020
EPS (diluted) -31.8%
FY 2017 FY 2020
Free Cash Flow 6.2%
FY 2017 FY 2020
Financial Health
Current Ratio 1.9×
FY 2017 5y median 3.8× FY 2020
Quick Ratio 1.9×
FY 2017 5y median 3.8× FY 2020
Debt / Equity -1.5×
FY 2017 5y median 0.0× FY 2020
Net Debt / EBITDA -0.2×
FY 2017 5y median 0.2× FY 2020
Interest Coverage 39.9×
FY 2017 5y median 19.9× FY 2020
Dividends
Dividend Yield 0.0%
FY 2017 5y median 0.0% FY 2020
Payout Ratio 0.0%
FY 2017 5y median 0.0% FY 2020
Annual · latest fiscal year ends 2020-03-31